Levitra

Alternatively, you could bring the subject up (as it were) gently, with accompanying praise for his sexual prowess.

Though how you explain why you were poking around in his drawers is probably the trickier question.

You'll be counting his condoms next.If you do find he is self-medicating, send him to a doctor - the unmonitored side-effects of the drugs can be serious.

When you dream of heart-stopping sex, a cardiac arrest isn't usually what you're after.· If you have a question for sebastian and Marion, email sex@observer.co.uk Observer sections _______________________ Business Cash Comment Focus International Leaders Letters Life Politics Review Screen Sport Travel UK news style guideserver contacts 7 days worldSport MonthlyFood Monthly2001 electionPress freedom campaign Privacy policy About this siteGuardian Unlimited © Guardian Newspapers Limited 2006 ...

The venture reported it will have to conduct more phase 2 human trials to see if Cialis' active ingredient, tadalafil, can treat a common prostate problem.

Fitzpatrick said the Food and Drug Administration wants the company to collect more data on various doses of the drug.

That will probably delay the final phase 3 trial and potential approval of the drug for that use by about a year, Latta said.

ICOS also is testing tadalafil as a treatment for high blood pressure and pulmonary arterial hypertension, a potentially fatal lung disorder.

Reporter Eric Fetters: 425-339-3453 or fetters@heraldnet.com.

Cialis sales Since Cialis first went on sale in some parts of the world in early 2003, the drug has racked up more than $1.5 billion in worldwide sales, according to Bothell-based ICOS.

That gross sales total equals the cost of 10 Boeing 787-8 jetliners, or six 777-300ERs at list prices.

Cialis sales Since Cialis first went on sale in some parts of the world in early 2003, the drug has racked up more than $1.5 billion in worldwide sales, according to Bothell-based ICOS.

That gross sales total equals the cost of 10 Boeing 787-8 jetliners, or six 777-300ERs at list prices.

Home Delivery Special3 months for $25 Click here and subscribe to convenient home delivery today!

What's Hot on HeraldNet?

View the most popular HeraldNet storiesbeing e-mailed around today.

Featured Advertiser clic...

Viagra sales declined 2 percent to $1.6 billion in 2005, said Pfizer in its earnings report on Thursday.

Viagra sales dropped 8 percent in the fourth quarter to $430 million.

Pfizer attributed the sales decline to "slower growth in the overall erectile-dysfunction market and competition from other products." Full year sales figures for Competition heating up in 2006 Prior to today's report, Al Rauch, analyst for A.G.

Edwards & Sons, projected that Cialis sales would reach $900 million in 2006.

Many analyst believe that the market for sexual dysfunction drugs has reached capacity, meaning more intensified competition between drug makers as they battle for market share.

Lilly spokesman Phil Belt said the sales growth for Cialis was "built largely on market share gain" and Lilly is marketing its product as significantly different from its competitors.

Belt said that Cialis has a "convenient" 36-hour window for men suffering from impotence, allowing them to achieve erection during that time if stimulated.

Pfizer is also trying to expand market share with a recently launched education campaign about erectile dysfunction that does not spec...